Overview

Efficacy and Safety Study of Eravacycline Compared With Ertapenem in Participants With Complicated Urinary Tract Infections

Status:
Completed
Trial end date:
2018-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the efficacy, safety, and pharmacokinetics of eravacycline compared to ertapenem in treating participants with complicated urinary tract infections (cUTI).
Phase:
Phase 3
Details
Lead Sponsor:
Tetraphase Pharmaceuticals, Inc.
Treatments:
Ertapenem
Levofloxacin
Ofloxacin